New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
11:38 EDTZMHZimmer recalls all 315 units of PEEK Ardis Inserter, FDA says
The FDA posted on its website that Zimmer issued a December 21 recall of its PEEK Ardis Inserter. Zimmer Spine has received reports of the PEEK Ardis Interbody Spacer breaking into fragments when too much lateral force is applied to the Ardis Inserter, the FDA said. If the PEEK Ardis Interbody Spacer breaks during implantation, surgical delays of up to 60 minutes could occur and health risks may include a tear in the thin covering of the spinal cord, cerebrospinal fluid leakage, significant blood loss and nerve injury, the agency added. On Dec. 20, Zimmer Spine modified their Medical Device Correction memo and initiated a voluntary recall of all 315 units of the PEEK Ardis Inserter.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
08:17 EDTZMHZimmer says company to be renamed Zimmer Biomet after deal closing
Subscribe for More Information
October 28, 2014
06:21 EDTZMHZimmer price target raised to $119 from $105 at Jefferies
Jefferies maintained its Hold rating on Zimmer and raised its price target to $119 from $105 due to Biomet deal accretion.
October 23, 2014
11:13 EDTZMHZimmer price target raised to $150 from $125 at Brean Capital
Subscribe for More Information
08:59 EDTZMHZimmer expects capital spend to reduce significantly in 2015, going into 2016
08:33 EDTZMHZimmer 'very pleased' with integration planning with Biomet combination
The company is all on track, if not ahead of schedule. The tone of the integration is especially pleasing to the company. The company expects the closing to occur sometime in Q1, though it is not clear whether it will be in the beginning or the end of the quarter.
08:24 EDTZMHZimmer expects accretion from Biomet merger applies to 12 months after closing
Subscribe for More Information
08:23 EDTZMHZimmer: Q4 will experience seasonally lower expense ratios
08:23 EDTZMHZimmer reports FY14 gross margin ratio to be 73%-74%
Subscribe for More Information
07:32 EDTZMHZimmer raises FY14 adjusted EPS to $6.05 from $6.00-$6.10, consensus $6.04
Subscribe for More Information
07:30 EDTZMHZimmer reports Q3 adjusted EPS $1.35, consensus $1.30
Subscribe for More Information
October 22, 2014
15:37 EDTZMHNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Comcast (CMCSA), consensus 71c; Union Pacific (UNP), consensus $1.52; 3M (MMM), consensus $1.96; AbbVie (ABBV), consensus 77c; Celgene (CELG), consensus 95c; Eli Lilly (LLY), consensus 67c; Occidental Petroleum (OXY), consensus $1.57; Caterpillar (CAT), consensus $1.36; Alexion Pharmaceuticals (ALXN), consensus $1.16; Precision Castparts (PCP), consensus $3.32; Raytheon (RTN), consensus $1.60; American Electric Power (AEP), consensus $1.02; Southwest Airlines (LUV), consensus 53c; Lorillard (LO), consensus 90c; T. Rowe Price (TROW), consensus $1.15; Mead Johnson (MJN), consensus 91c; Zimmer Holdings (ZMH), consensus $1.30; Nucor (NUE), consensus 73c; Nielsen (NLSN), consensus 65c; Prologis (PLD), consensus 46c; Sigma-Aldrich (SIAL), consensus $1.06; Under Armour (UA), consensus 40c; EQT (EQT), consensus 56c; Dr Pepper Snapple (DPS), consensus 88c; Cameron International (CAM), consensus $1.10; Coca-Cola Enterprises (CCE), consensus 89c; Quest Diagnostics (DGX), consensus $1.08; CMS Energy (CMS), consensus 41c; Airgas (ARG), consensus $1.29; PulteGroup (PHM), consensus 36c; Diamond Offshore (DO), consensus 79c; Bemis (BMS), consensus 67c.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use